Cargando…
Heparanase augments insulin receptor signaling in breast carcinoma
Recently, growing interest in the potential link between metabolic disorders (i.e., diabetes, obesity, metabolic syndrome) and breast cancer has mounted, including studies which indicate that diabetic/hyperinsulinemic women have a significantly higher risk of bearing breast tumors that are more aggr...
Autores principales: | Goldberg, Rachel, Sonnenblick, Amir, Hermano, Esther, Hamburger, Tamar, Meirovitz, Amichay, Peretz, Tamar, Elkin, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386693/ https://www.ncbi.nlm.nih.gov/pubmed/28038446 http://dx.doi.org/10.18632/oncotarget.14292 |
Ejemplares similares
-
Regulation of Heparanase in Diabetes-Associated Pancreatic Carcinoma
por: Goldberg, Rachel, et al.
Publicado: (2019) -
Macrophages Upregulate Estrogen Receptor Expression in the Model of Obesity-Associated Breast Carcinoma
por: Nahmias Blank, Daniela, et al.
Publicado: (2022) -
Radiation-Induced Nephropathy in the Murine Model Is Ameliorated by Targeting Heparanase
por: Abecassis, Alexia, et al.
Publicado: (2023) -
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
por: Zahavi, Tamar, et al.
Publicado: (2021) -
Induction of heparanase by HPV E6 oncogene in head and neck squamous cell carcinoma
por: Hirshoren, Nir, et al.
Publicado: (2014)